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and ‡Department of Physiology, University of Cologne, Cologne, GermanyABSTRACT Caldesmon is an actin- and myosin-binding protein found in smooth muscle that inhibits actin activation of myosin
ATPase activity. The activity of caldesmon is controlled by phosphorylation and by binding to Ca2þ-calmodulin. We investigated
the effects of phosphorylation by p21-activated kinase 3 (PAK) and calmodulin on the 22 kDa C-terminal fragment of caldesmon
(CaD22). We substituted the major PAK sites, Ser-672 and Ser-702, with either alanine or aspartic acid to mimic nonphosphory-
lated and constitutively phosphorylated states of caldesmon, respectively. The aspartic acid mutation of CaD22 weakened
Ca2þ-calmodulin binding but had no effect on inhibition of ATPase activity. Phosphorylation of the aspartic acid mutant with
PAK resulted in the slow phosphorylation of Thr-627, Ser-631, Ser-635, and Ser-642. Phosphorylation at these sites weakened
Ca2þ-calmodulin binding further and reduced the inhibitory activity of CaD22 in the absence of Ca2þ-calmodulin. Phosphoryla-
tion of these sites of the alanine mutant of CaD22 had no effect on Ca2þ-calmodulin binding but did reduce inhibition of ATPase
activity. Thus, the region between residues 627 and 642 may contribute to the overall regulation of caldesmon’s activity.INTRODUCTIONRegulation of myosin-based motility can be achieved by
modifying either myosin or its cofactor, actin. Several actin-
binding proteins inhibit actin activation of myosin ATPase
activity. Troponin-tropomyosin confers Ca2þ sensitivity to
striated muscle (1). Other actin-binding proteins, such as cal-
desmon (2), calponin (3,4), and fesselin/synaptopodin 2 (5),
may inhibit actin-dependent movement in various cells.
A criterion for a biological function of these actin-binding
proteins is that their inhibitory effects must be reversible.
Ca2þ-calmodulin reverses the effects of caldesmon (2,6)
and calponin (4) on actin-activated ATPase activity. Ca2þ-
calmodulin also regulates the ability of synaptopodin 2 to
promote actin polymerization (7). Phosphorylation by
mitogen-activated protein (MAP) kinase (8) and p21-acti-
vated kinase (PAK) (9) has been reported to attenuate the
inhibitory effects of caldesmon. Phosphorylation of other
actin-binding proteins has been well documented (10,11).
Multiple signals, such as phosphorylation and ligand
binding (i.e., Ca2þ-calmodulin), may work synergistically
by altering the structure of some of these actin-binding
proteins. Several actin-binding proteins are known to have
unfolded regions that are often targets of signaling. Unfolded
regions of troponin I have been proposed to be involved in
actin binding and inhibition of muscle contraction (12).
Both CaD22 (13) and fesselin (14) are largely unfolded in
solution. Ca2þ-calmodulin binding to a COOH-terminal
caldesmon fragment induces folding (13). Because the
COOH-terminal region of caldesmon that regulates actomy-Submitted April 7, 2010, and accepted for publication July 14, 2010.
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calmodulin and phosphorylation, we wished to explore how
multiple signaling events affect its functions.
Phosphorylation by PAK was investigated here because
phosphorylation of intact l-caldesmon occurs in vivo (15).
The sites of phosphorylation of h-caldesmon are Ser-672
and Ser-702 (9,15). Constitutively active PAK3 produces
Ca2þ- independent contraction of smooth muscle (16).
PAK kinase is also a major regulator of caldesmon-mediated
actin dynamics in vivo (15,17).
We observed that PAKphosphorylated four additional resi-
dues within the region 627–642 of caldesmon. Phosphoryla-
tion at these sites alone had little or no effect on CaD22
binding to Ca2þ-calmodulin. However, phosphorylation at
these sites did enhance the effect of phosphorylation of Ser-
672 and -702 (or on aspartic acid substitutions at sites 672
and 702) on weakening CaD22 binding to Ca2þ-calmodulin.
In addition, we found that phosphorylation at the minor sites
alone partially reversed the inhibitory activity of CaD22. We
made the latter observation by blocking phosphorylation at
residues 672 and 702 using alanine substitutions at those posi-
tions. Because of these different effects, we observed that the
effect of Ca2þ-calmodulin on the activity of caldesmon is
dependent on the combination of phosphorylated residues.
The interplay between signals resulting in phosphorylation
and Ca2þ-calmodulin binding may be quite complex.MATERIALS AND METHODS
Proteins
Actin and myosin were isolated from rabbit back muscle (18,19). Myosin
subfragment 1 was made by digestion of myosin with chymotrypsin (20).doi: 10.1016/j.bpj.2010.07.018
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ski, University of Illinois at Urbana-Champaign, Urbana, IL) was expressed
in Escherichia coli BL21 cells and prepared as described by (21). Smooth
muscle tropomyosin was isolated from turkey gizzards (22). A 22 kDa
C-terminal wild-type (WT) fragment (Met-563–Pro-771) and 35 kDa
C-terminal WT fragment (Met-461–Pro-771) of Gallus gallus caldesmon
(NCBI Protein Data Bank BAA04539), as well as the corresponding double
alanine and double aspartic acid mutants, were subcloned into a pSBET-A
expression vector (gift of H. H. Steinbiss, Max Plank Institute for Plant
Breeding Research, Cologne, Germany) expressed in E. coli BL21 cells
and purified according to Fredricksen et al. (23). PAK (GST-mPAK3,
a gift from Dr. Alan Mak, Queen’s University, Kingston, Canada) was
expressed in E. coli BL21 cells and prepared as described previously
(16). The concentrations of the different CaD22 fragments were determined
by means of a Lowry assay with bovine serum albumin as a standard. The
concentrations of other proteins were determined by absorbance at 280 nm
and corrected for scattering at 340 nm using the following extinction coef-
ficients E280
0.1%: actin, 1.15; smooth muscle tropomyosin, 0.22; myosin S1,
0.75; and calmodulin, 0.19. The molecular masses assumed for the key
proteins were myosin S1, 120,000 Da; actin, 42,000 Da; smooth muscle
tropomyosin, 68,000 Da; CaD22, 22,000 Da; CaD, CaD35, 35,000 Da;
and calmodulin, 16,800 Da.
The DNA sequence of the mutants was confirmed by cycle sequencing
with the ABI prism big dye terminator cycle sequencing ready reaction
kit. The products were resolved on an ABI prism 377 automated sequencer
(Perkin-Elmer/Applied Biosystems,Waltham, MA). The expressed mutants
were analyzed by matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MS).Phosphorylation of caldesmon
CaD22 (generally 1 mg/mL) was phosphorylated by constitutively active
GST-mPAK3 (~10 mg/mL). The extent of phosphorylation was determined
by nonequilibrium isoelectric focusing gel electrophoresis as described by
Kobayashi et al. (24). Gels contained 8 M urea, 5% acrylamide, 0.8%
ampholyte pH 3.0–10.0, and 1.2% ampholyte pH 8.0–10.0 (BioRad, CA).
Sample loading buffer contained 8 M urea, 10 mM EDTA, and 1% ampho-
lyte pH 3.0–10.0. The running times were 30 min at 100 V, 40 min at 200 V,
and 20 min at 500 V. The gels were soaked in fixing solution containing
10% methanol and 5% acetic acid, and then stained with Coomassie Blue
R350.
The time courses of phosphorylation were determined by measuring the
incorporation of 32P into caldesmon fragments at various time intervals with
a filter paper assay (25). Caldesmon fragments were phosphorylated by
PAK at 25C in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2,
1 mM dithiothreitol, and 1 mM 32P-ATP (4105 cpm/nmol). Aliquots
were drawn at different times after initiation of phosphorylation and placed
onto Whatman grade 3 filter circles (2.3 cm diameter). Filters were dropped
immediately into ice-cold 10% TCA, 8% sodium pyrophosphate (w/v), fol-
lowed by three subsequent washes for 10–15 min with 10% TCA, 2%
sodium pyrophosphate at room temperature. The filters were then washed
in 95% ethanol and finally in acetone. The 32P activity of the filters was
determined by liquid scintillation counting.
The sites of phosphorylation were identified by MS. The CaD22 protein
bands were excised from SDS gels, reduced, alkylated, and digested with
modified trypsin (Promega). The peptides were analyzed by liquid chroma-
tography-tandem MS (LC-MS/MS) using capillary high-performance
liquid chromatography with a 75 mm nanocolumn and a Thermo Electron
LTQ quadrupole ion trap mass spectrometer. The resulting masses and
spectra were searched against a database using TurboSequest (26,27)
with the Proteomics Browser interface (William Lane, Harvard Micro-
chemistry and Proteomics Analysis Facility). Extracted ion chromatograms
of full MS scans were performed on the m/z values that matched the phos-
phorylated peptides and corresponding nonphosphorylated peptides using
a mass error window of55 ppm. The peptide identities of integrated peaksBiophysical Journal 99(6) 1861–1868were verified based on retention times of the MS/MS spectra. Mass spectral
analysis was performed at the Wistar Proteomics Facility, Philadelphia, PA.ATPase rate measurements
Rates were determined by measuring the time dependence of 32Pi formation
from g32P-labeled ATP at 25C. The concentrations of actin, smooth
muscle tropomyosin, and myosin S1 were 10 mM, 2.2 mM, and 0.1 mM,
respectively. The final solution composition was 1 mM ATP, 3 mM
MgCl2, 31 mM NaCl, 10 mM imidazole pH 7.0. The reaction volume
was 1 mL. Aliquots of 0.2 mL were removed at different time points and
quantified as described previously (28). Four or more time points were
taken to establish each rate.Calmodulin binding
Ca2þ-calmodulin binding was determined by changes in intrinsic trypto-
phan fluorescence of CaD22. Fluorescence measurements were made on
an Aminco Bowman II luminescence spectrometer (Thermo Electron,
Madison, WI). The cell compartment was maintained at 20C with a circu-
lating bath in a buffer containing 10 mM MOPS pH 7.2, 100 mM NaCl,
1 mM dithiothreitol, 2 mM CaCl2. Tryptophan fluorescence was measured
with excitation and emission monochomators set to 295 nm and 340 nm,
respectively. Low protein concentrations were used to avoid inner filter
effects. Spectra were corrected for the fluorescence contribution from
calmodulin in the same buffer solution and for wavelength-dependent
lamp output. Because calmodulin lacks tryptophan residues, the correction
for calmodulin was <5%.RESULTS
To study PAK regulation of CaD22, we modified the two
major phosphorylation sites of chicken gizzard CaD22:
Ser-672 and Ser-702. Serine-to-alanine substitutions were
made to mimic the nonphosphorylated state (CaD22AA).
The phosphorylated state was mimicked by replacing both
serine residues with aspartic acid residues (CaD22DD). The
presence of the correct mutations was verified by sequencing
both plasmids. ForCaD22WT the observedmass (22,625Da)
was consistent with the calculated mass (22,630 Da). Similar
agreement was obtained for the observed mass (22,690 Da)
and calculated mass (22,686 Da) of CaD22DD. In both
cases the observed masses were within 0.02% of the calcu-
lated ones.
The presence of additional charges in the CaD22DD
mutant was verified with the use of nonequilibrium isoelec-
tric focusing gels. The theoretical pI values for CaD22 and
CaD22DD are 9.7 and 9.56, respectively. Fig. 1 shows that
CaD22DD (lane 2) migrated less toward the cathode
than did CaD22WT (lane 1). The migration of the AA
mutant was identical to the WT (not shown). CaD22WT,
CaD22AA, and CaD22DD migrated similarly on SDS gels
(data not shown).
We examined the time course of PAK phosphorylation of
CaD22WT by means of isoelectric focusing. Fig. 1 shows
untreated CaD22WT (lane 3) and CaD22WT that was
treated with PAK for 1.5 h (lane 4) and 20 h (lane 5).
Untreated CaD22 focused as two closely spaced bands.
FIGURE 1 Nonequilibrium isoelectric focusing showing charge changes
in CaD22 after mutations or PAK phosphorylation. Lane 1: CaD22WT; lane
2: CaD22DD; lane 3: CaD22WT; lane 4: CaD22WT PAK phosphorylated
for 1.5 h; lane 5: CaD22WT PAK phosphorylated for 20 h; lane 6:
CaD22DD; lane 7: CaD22DD after incubation for 20 h with PAK; lane 8:
CaD22AA; lane 9: CaD22AA after incubation for 20 h with PAK. The
cathode is at the bottom of each gel.
FIGURE 2 Two sets of sites on CaD22 were phosphorylated by extended
treatment with PAK. The phosphorylation time courses were followed by
32Pi incorporation at 25C in a buffer containing 20 mM Tris-HCl
pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, and 1 mM
32P-ATP (4105 cpm/nmol). Both CaD22WT (open circles) and CaDAA
(solid circles) are shown. Phosphorylation at sites other than Ser-672 and
Ser-702 is evident in both cases.
FIGURE 3 Phosphorylation at both the major and minor sites of CaD22
decreased the affinity to Ca2þ-calmodulin. Binding was measured to CaD22
(open circles), CaD22 treated for 1.5 h (dotted circles), and CaD22 treated
for 20 h with PAK (solid circles). The data shown are from four, one, and
three data sets, respectively. Phosphorylation at the major sites (dotted
circles) reduced the affinity from 0.11 mM to 0.8 mM. Additional phosphor-
ylation to yield 3.3 Pi/caldesmon reduced the affinity to 4.0 mM. The dotted
lines represent 95% confidence intervals for each curve. Inset: Plot of the
fraction of maximum binding against log[CaMfree]. The reaction buffer
contained 10 mM MOPS pH 7.2, 100 mM NaCl, 1 mM dithiothreitol,
2 mM CaCl2 at 20
C. CaD22 concentration was 0.6 mM.
Caldesmon Phosphorylation by PAK 1863The number of bands with lower isoelectric points increased
with time of incubation. SDS gels showed that the
CaD22WT remained intact during those periods of incuba-
tion (data not shown). These time-dependent shifts raised
the possibility that more than two sites within CaD22WT
became phosphorylated.
To test that possibility, we examined whether CaD22DD
and CaD22AA could be phosphorylated by PAK. Fig. 1
shows CaD22DD before (lane 6) and after (lane 7) a 20 h
incubation with PAK. Fig. 1 shows CaD22AA before
(lane 8) and after (lane 9) a 20 h incubation with PAK.
The additional acidic bands present in both cases indicate
that additional phosphorylation sites were present.
Fig. 2 shows the time courses of phosphorylation of
CaD22WT and CaD22AA by PAK. CaD22WT was phos-
phorylated to yield 2 mol phosphate/mol CaD22 (open
circles) in the first phase. Upon continued incubation, the
caldesmon fragment slowly incorporated additional phos-
phate residues, yielding 3.3 mol phosphate/mol CaD22 after
23 h. When the study was repeated with CaD22AA having
the two major PAK sites blocked, the first phosphorylation
phase was absent, but the additional slow phosphorylation
still occurred (solid circles).
The effect of phosphorylation at the major and minor sites
of CaD22 on Ca2þ-calmodulin binding was determined with
intrinsic tryptophan fluorescence measurements. Fig. 3
compares Ca2þ-calmodulin binding isotherms for CaD22
that was nonphosphorylated, phosphorylated only at the
major sites, and phosphorylated at both the major and minor
sites. Phosphorylation at the major sites reduced the affinityof CaD22 for Ca2þ-calmodulin from 0.11 mM (open circles)
to 0.8 mM (dotted circles). More extensive phosphorylation
(solid circles) caused a further reduction in the binding
affinity, to ~4.0 mM. An examination of the 95% confidence
limits shows that the three binding curves were statistically
different.
The study shown in Fig. 3 was repeated with mutants of
CaD22 lacking the major phosphorylation sites. CaD22AA
lacks charges at the major sites and cannot be phosphory-
lated at these sites. Fig. 4 A compares unphosphorylatedBiophysical Journal 99(6) 1861–1868
FIGURE 4 Effect of phosphorylation at the minor sites of CaD22AA (A)
and CaD22DD (B) on calmodulin binding. CaD22 decreased calmodulin
binding only when the major sites were negatively charged. (A) Binding
to CaD22AA (open triangles, four data sets) was identical to that of WT
(open circles, four data sets) and was unaffected by PAK treatment for
20 h (solid triangles, three data sets). The solid circles (from Fig. 3)
show the effect of extended PAK treatment of WT caldesmon. Phosphory-
lation of CaD22AA increased the affinity for Ca2þ-calmodulin slightly
(Kd decreased from 0.1 mM to 0.04 mM). The inset shows the fraction of
maximum binding versus log[CaMfree]. (B) Substituting PAK phosphoryla-
tion sites with Asp (i.e., CaD22DD; open triangles, three data sets) reduced
the affinity of CaD22 to Ca2þ-calmodulin to 1.15 mM compared with
0.1 mM for WT unphosphorylated (open circles, four data sets). Incubation
of CaD22DD with PAK for 20 h (solid triangles, three data sets) caused
a further reduction in its affinity of binding to calmodulin to 3.1 mM. The
dotted lines represent 95% confidence intervals for each curve. The solid
circles represent CaD22WT incubated with PAK for 20 h. Conditions are
the same as in Fig. 3.
FIGURE 5 Ca2þ-calmodulin binding decreased the rate of phosphoryla-
tion of the minor sites by PAK. Phosphorylation time courses were
measured as described in Fig. 2 with 0.5 mM CaD22AA and 2 mM Ca2þ-
calmodulin. Phosphorylation time courses of CaD22AA in the absence
(open triangles) and presence (open squares) of Ca2þ-calmodulin are
shown. Ca2þ-calmodulin was not appreciably phosphorylated by PAK
(open circles).
1864 Hamden et al.CaD22AAwith CaD22AA that was treated with PAK for up
to 20 h. Although this treatment caused phosphorylation at
the minor sites, the affinity for Ca2þ-calmodulin was
unaffected. The affinities of both phosphorylated and non-
phosphorylated CaD22AA for Ca2þ-calmodulin were
similar to that of CaD22WT (Fig. 4 A); that is, curves for
both phosphorylated and nonphosphorylated CaD22AA
fell within the 95% confidence interval for the WT curve.
CaD22DD had negative charges at the major sites, and
incubation with PAK led to phosphorylation of only the
minor sites. CaD22DD bound more weakly to Ca2þ-
calmodulin than did CaD22WT (Fig. 4 B). Treatment of
CaD22DD with PAK caused a further reduction in the
binding affinity, bringing it close to that of the phosphory-
lated CaD22WT (Fig. 4 B). The results of Fig. 4 suggestBiophysical Journal 99(6) 1861–1868that phosphorylation of caldesmon at the unknown sites
affected Ca2þ-calmodulin binding only if the two major
PAK sites were already phosphorylated.
Phosphorylation of CaD22 may have altered the stoichi-
ometry of binding to calmodulin in addition to decreasing
the stability of the interaction.We determined the stoichiom-
etry by repeating binding studies at CaD22 concentrations
that exceeded the dissociation constant for the CaD22-
calmodulin complex. These data are presented in Fig. S1 of
the Supporting Material. As the concentration of calmodulin
was increased, a plateau of binding was reached at the same
ratio of calmodulin to caldesmon for all of the CaD
constructs. CaD22 formed 2:1 complexes with Ca2þ-
calmodulin, in agreement with previously reported data (29).
Because phosphorylation of caldesmon by PAK on the
minor sites affected binding to Ca2þ-calmodulin, we
measured the effect of Ca2þ-calmodulin on the time course
of phosphorylation of CaD22AA by PAK (Fig. 5). In the
presence of Ca2þ-calmodulin (open squares), the
phosphorylation of the minor sites was significantly slower
than in the absence of Ca2þ-calmodulin (open triangles).
PAK did not phosphorylate Ca2þ-calmodulin significantly
(open circles).
Phosphorylation of caldesmon reduces the ability of
caldesmon to inhibit actin activation of myosin S1 ATPase
activity (9). We examined the contribution of the major
and minor PAK phosphorylation sites on the inhibitory
activity of CaD22. CaD22AA was expected to behave like
CaD22WT. As shown in Fig. 6, CaD22AA had the same
inhibitory activity as CaD22WT (Fig. 6, open triangles
down and open circles). The mutant designed to mimic
phosphorylation at sites 672 and 702 was expected to have
a diminished inhibitory activity. However, CaD22DD
(Fig. 6, open triangles up) had the same inhibitory activity
as CaD22WT and CaD22AA. After overnight incubation
FIGURE 6 Phosphorylation of the minor sites of CaD22 reduced the
inhibition of actomyosin ATPase activity. Actin-activated S1-ATPase as
a function of phosphorylated and unphosphorylated CaD22WT (circles),
CaD22DD (triangles up), and CaD22AA (triangles down) is shown.
Open symbols show the effect of unphosphorylated CaD22, whereas solid
symbols show the corresponding species after 20 h treatment with PAK.
The inset shows actin-activated S1-ATPase as a function of the concentra-
tions of CaD35WTand CaD35DD. Actin, smooth muscle tropomyosin, and
myosin S1 were 10 mM, 2.2 mM, and 0.1 mM, respectively. The final
solution composition was 1 mM ATP, 3 mM MgCl2, 31 mM NaCl,
10 mM imidazole pH 7.0, at 25C.
FIGURE 7 Ca2þ-calmodulin has different effects on the inhibitory activ-
ities of unphosphorylated and highly phosphorylated CaD22. Shown are un-
phosphorylated CaD22WT (open circles), CaD22WT-PAK incubated with
PAK for 20 h (solid circles), and CaD22DD (triangles). Conditions are the
same as in Fig. 6 except that [CaD22] was held constant at 1.1 mM.




RLEQYTSAVVGNK 1464.7805 1464.7836 2.1 ppm
RLEQYTS(642)AVVGNK 1544.7469 1544.7499 2.0 ppm
PAHTTAVVSK 1010.5629 1010.5627 0.8 ppm
PAHTTAVVS(631)K 1090.5293 1090.5279 1.3 ppm
IDSRLEQYTSAVVGNK N/A
IDS(635)RLEQYTSAVVGNK 1859.8899 1859.8945 1.0 ppm
SGMKPAHTTAVVSK 1413.7519 1413.7548 0.1 ppm
SGMKPAHTT(627)AVVSK 1493.7182 1493.7174 0.5 ppm
Phosphorylated residues are in bold and residue numbers are in parentheses.
Caldesmon Phosphorylation by PAK 1865with PAK, both the mutants and CaD22WT had similarly
reduced inhibitory activities (Fig. 6, solid symbols). Because
the minor sites were not totally phosphorylated, the total
extent of reversal of activity was not determined. These
results suggest that the introduction of negative charges
into the minor sites (but not the major sites) attenuated the
inhibitory activity of CaD22.
To ensure that all our proteins functioned normally, we
measured the rate of actin-activated ATPase activity as
a function of CaD22WT. The CaD22 produced inhibition
that was typical of caldesmon. In particular, tropomyosin
markedly enhanced the inhibitory activity of CaD22. These
data are shown in Fig. S2.
We also examined the effects of negative charges at sites
672 and 702 in a larger caldesmon construct, CaD35, which
was previously characterized in our laboratory (23). The
inset in Fig. 6 shows that CaD35DD had the same ability
to inhibit actin-stimulated ATPase activity as CaD35WT.
The results presented to this point indicate that the effect
of Ca2þ-calmodulin on ATPase activity may depend on the
level of phosphorylation of CaD22. We investigated that
possibility by comparing the calmodulin dependency of
ATPase activities of unphosphorylated and phosphorylated
CaD22. Ca2þ-calmodulin was effective in reversing
CaD22WT inhibition of actomyosin ATPase (Fig. 7, open
circles) but was not able to effectively reverse the inhibition
by CaD22DD in which only the major PAK sites were nega-
tively charged (triangles); that is, when the major PAK sites
were negatively charged, caldesmon was inhibitory even in
the presence of Ca2þ-calmodulin. When CaD22 was phos-
phorylated at both the major and minor sites with PAK
(solid circles), there was less inhibition of ATPase activityin the absence of Ca2þ-calmodulin, and Ca2þ-calmodulin
had little effect on the degree of inhibition.
The minor sites of phosphorylation of CaD22 by PAK
were identified by MS. The sites of phosphorylation
together with the masses are given in Table 1. Phosphory-
lated Thr-627 and Ser-631 were more abundant than phos-
phorylated Ser-635 and Ser-642. The localization of these
sites relative to MAP kinase sites (30), calmodulin kinase
II sites (31), cdc2 kinase sites (32), and PKC sites (33) is
shown in Fig. 8. Sample MS spectra of phosphorylated
peptides are given in Fig. S3.
It is not clear whether all of the minor sites, a combination
of these sites, or just one site is responsible for the observed
functional effects. We mutated Thr-627 to Asp in CaD22DD
to mimic the phosphorylated state of that minor site and the
two major sites. The sequences of the DNA and mutant were
verified. The observed mass difference between the triple
mutant and the WT caldesmon (68 Da) agreed with the
calculated difference (70 Da).
Fig. 9 shows that the affinity of the triple mu-
tant, CaD22DDD, for Ca2þ-calmodulin was weaker than
that for CaD22WT (open circles), but stronger than that of
CaD22-PAK (long dashed line). The binding affinity of the
triple mutant was similar to that of CaD22DD (shortBiophysical Journal 99(6) 1861–1868
FIGURE 8 Phosphorylation sites on CaD22. All phosphorylation sites
are in bold. Major PAK kinase sites are in square brackets. Minor PAK sites
are in parentheses. MAPK sites1, calmodulin kinase II sites2, cdc2 kinase
sites3, and PKC sites4 are indicated with superscripts as shown. The tropo-
myosin-binding region has a single underline. The calmodulin-binding
regions have a double underline.
FIGURE 9 Aspartate substitution at Thr-627 in combination with aspar-
tate substitutions at the major sites did not affect calmodulin binding.
Calmodulin binding curves for WT (open circles, four data sets), triple
mutant (open diamonds, three data sets), and triple mutant after 20 h
PAK treatment (solid diamonds, two data sets) are shown with their 95%
confidence limits (dotted lines). The binding curve for the triple mutant
(Kd ¼ 1.5 mM) was similar to that of CaD22DD (short dashed line,
Kd¼1.6 mM). PAK phosphorylation of the triple mutant reduced the affinity
to 4.5 mM, which is similar to that observed for CaD22WT-PAK (vertical
bar line). Conditions are the same as in Fig. 3.
1866 Hamden et al.dashed line), which has negative charges only on the major
sites.
Treatment of the triple mutant with PAK reduced the
binding affinity, bringing it close to that of the phosphory-
lated CaD22WT. This suggests that the Thr-627 residue
by itself does not affect Ca2þ-calmodulin binding to caldes-
mon phosphorylated on the major sites.
Because phosphorylation of the minor sites plays a role in
controlling inhibition of ATPase activity by caldesmon
(Fig. 6), we explored the effects of the triple mutant on
the ATPase activity of caldesmon. The triple mutant had
the same inhibitory activity as CaD22WT and did not
exhibit the reduced inhibitory activity, as the WT phosphor-
ylated by PAK on both the major and minor residues. These
data are shown in Fig. S4.DISCUSSION
PAK kinase phosphorylates caldesmon at Ser-672 and
Ser-702 (9). Phosphorylation at these sites reduces binding
to calmodulin and results in a partial reversal of the inhibi-
tory action of caldesmon on actomyosin ATPase activity
(9,15). We confirmed the effect of phosphorylation on
calmodulin binding, but observed little change in ATPase
inhibitory activity. Phosphorylation at Thr-627, Ser-631,
Ser-635, and Ser-642 further weakened calmodulin binding
and partially reversed ATPase activity. Serine residues at
sites 672 and 702 were substituted with either aspartic
acid (CaD22DD) or alanine (CaD22AA) to simulate the
phosphorylated and nonphosphorylated states, respectively.
This procedure permitted us to investigate the relationship
among the major (672 and 702) and minor (627, 631, 635,
and 642) sites of phosphorylation.
In the case of phosphorylated CaD22WT, the affinity for
Ca2þ-calmodulin decreased after further incubation with
PAK. This further incubation was accompanied by phos-
phorylation at the minor sites. To ensure that the further
reduction in affinity was not linked to an increase in phos-
phorylation of the major sites, we utilized CaD22DD. The
affinity of CaD22DD for Ca2þ-calmodulin was ~10% ofBiophysical Journal 99(6) 1861–1868that observed with CaD22WT. Incubation of CaD22DD
with PAK caused a further reduction in affinity for
Ca2þ-calmodulin to ~3% of the WT affinity. The effect of
phosphorylation of the minor sites on Ca2þ-calmodulin
binding was dependent on the prior phosphorylation of the
major sites. Replacement of serine residues 672 and 702
by alanine had no effect on Ca2þ-calmodulin binding
compared to CaD22WT. Incubation of CaD22AA with
PAK did not weaken Ca2þ-calmodulin binding, although
the minor sites became phosphorylated; that is, the only
effect that phosphorylation of the minor sites had on
Ca2þ-calmodulin binding was to enhance the effect of phos-
phorylation at the major sites.
The effect of phosphorylation at the major PAK sites on
weakening Ca2þ-calmodulin binding is easy to rationalize
because these sites are adjacent to the Ca2þ-calmodulin
binding region of caldesmon. However, the minor phosphor-
ylation sites are ~30 residues upstream from the closest
known calmodulin-binding site (Fig. 8). We explored the
effect of calmodulin binding on the time course of PAKphos-
phorylation of CaD22AAwith the two major sites blocked.
Phosphorylation of the minor sites was significantly slower
in the presence of Ca2þ-calmodulin than in the absence of
Ca2þ-calmodulin (Fig. 5). Ca2þ-calmodulin binding to
caldesmon impedes PAK access to the minor sites.
Our results do not indicate how the structure of caldes-
mon is changed by Ca2þ-calmodulin binding. Because the
COOH-terminal region of caldesmon is largely unstructured
(13), many types of structural changes are possible. There is
evidence that the COOH-terminal region of caldesmon can
fold over upon itself (29) and such changes might alter the
exposure of regions of caldesmon to the kinase. PAK
Caldesmon Phosphorylation by PAK 1867phosphorylation does not appear to cause a gross change in
the way that caldesmon binds to calmodulin, since two
molecules of caldesmon bind to each molecule of calmod-
ulin regardless of the level of phosphorylation (Fig. 5).
Foster et al. (9) found that PAK phosphorylation of intact
chicken gizzard caldesmon caused a slight reduction in the
affinity for actin-tropomyosin. However, they also observed
a significant effect of phosphorylation on actin-tropomy-
osin-activated ATPase activity of myosin S1. Whereas WT
caldesmon reduced the ATPase activity to 20%, caldesmon
containing two phosphorylated residues produced only 45%
inhibition. Eppinga et al. (15) observed an even larger effect
of phosphorylation on a 39 kDa fragment of human caldes-
mon. They reported a complete reversal of inhibitory
activity when the major PKA sites were mutated to gluta-
mate residues (CaD39-PAKE).
We did not find a significant ATPase effect of phosphor-
ylation at the major sites of expressed 22 and 35 kDa regions
of chicken gizzard caldesmon. The phosphomimetic mutant
of the major sites, CaD22DD, had the same inhibitory
activity as CaD22 and CaD22AA. Furthermore, introducing
negative charges at sites 672 and 702 had no effect on the
inhibitory activity of the larger caldesmon construct,
CaD35. Note that CaD39 and CaD35 are the same physical
size despite the different notations used. Prolonged incuba-
tion of CaD22WT, CaD22DD, and CaD22AAwith PAK did
attenuate their inhibitory activities, and all to the same
extent; that is, phosphorylation of the minor sites of our
construct was necessary for reversal of inhibitory activity
irrespective of the state of residues 672 and 702.
PAK phosphorylation not only attenuates the inhibitory
activity of caldesmon, it also indirectly increases inhibitory
activity by weakening binding to Ca2þ-calmodulin. Fig. 7
shows that the net activity depends on the concentration of
Ca2þ-calmodulin and the number of caldesmon sites that
are phosphorylated. For all caldesmon species examined,
the acto-S1 ATPase rates increased with increasing calmod-
ulin concentrations. The rates of ATP hydrolysis in the
presence of CaD22DD (mimicking phosphorylation of the
major sites) were lower than those of WT at all calmodulin
concentrations. Caldesmon that was phosphorylated at the
minor and major sites had less inhibitory activity than WT
at low calmodulin concentrations, but the difference was
abolished at high calmodulin concentrations.
It is interesting that a caldesmon mutant that is defective
in Ca2þ-calmodulin binding sites fails to be recruited to
podosomes, and fails to suppress podosome formation
(34). Selective control of caldesmon phosphorylation may
produce similar changes in calmodulin binding and similar
cellular effects.
Phosphorylation of the minor sites of caldesmon by PAK
was very slow. It is possible that binding to some target
molecule can alter the ability of the minor caldesmon sites
to become phosphorylated. It is also possible that another
kinase is able to rapidly phosphorylate the minor sites ofcaldesmon. To facilitate identification of possible kinases,
we identified the minor PAK phosphorylation sites of cal-
desmon: Thr-627, Ser-631, Ser-635, and Ser-642. The loca-
tion of these sites within CaD22 is shown in Fig. 8.
A semiquantitative analysis of the extracted ion chromato-
grams showed that Thr-627 and Ser-631 carry the greatest
amounts of phosphate, and Ser-642 has the least amount
of phosphate. All four sites are clustered together, and are
located within the tropomyosin-binding region (residues
621–672 (35)).
The location of these minor phosphorylation sites within
the tropomyosin-binding region of caldesmon does not
appear to have a great impact on the role of tropomyosin.
The data of Fig. 6 show that phosphorylation of the minor
sites of CaD22 reduced the inhibition of ATPase activity
by ~28% in the presence of tropomyosin. We observed
with CaD35 that phosphorylation of these sites reduced
the inhibitory activity by 18% even in the absence of tropo-
myosin (data not shown). We did not observe significant
differences between CaD22 and CaD35, so it is unlikely
that phosphorylation of the minor sites has large effects on
the role of tropomyosin.
If phosphorylation of the minor PAK sites (Thr-627,
Ser-631, Ser-635, and Ser-642) serves a physiological role,
they are likely to be phosphorylated more rapidly than was
observed here. These sites could be better substrates for other
kinases, or phosphorylation may be linked to binding of cal-
desmon to a particular ligand. For example, it is known that
Ser-635 is a substrate for calmodulin-dependent protein
kinase II (31).
It also remains to be determined which of the minor sites
are involved in the changes reported here. Substitution of
Thr-627 with Asp did not produce the same effects observed
by phosphorylation at the minor sites with PAK kinase.
We conclude that phosphorylation of another minor site or
a combination of minor sites is important for modulating
both ATPase activity and calmodulin binding.SUPPORTING MATERIAL
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